[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Gastric Motility Disorder Drug Market Report 2017

December 2017 | 98 pages | ID: U3046C30E78EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Gastric Motility Disorder Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Gastric Motility Disorder Drug in these regions, from 2012 to 2022 (forecast).
United States Gastric Motility Disorder Drug market competition by top manufacturers/players, with Gastric Motility Disorder Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Theravance, Inc.
  • Helsinn Healthcare S.A.
  • Concert Pharmaceuticals, Inc.
  • Targacept, Inc.
  • ChironWells GmbH
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Velusetrag
  • Ipamorelin
  • TD-8954
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Hospital
  • Clinic
  • Home Use
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Gastric Motility Disorder Drug Market Report 2017

1 GASTRIC MOTILITY DISORDER DRUG OVERVIEW

1.1 Product Overview and Scope of Gastric Motility Disorder Drug
1.2 Classification of Gastric Motility Disorder Drug by Product Category
  1.2.1 United States Gastric Motility Disorder Drug Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Gastric Motility Disorder Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Velusetrag
  1.2.4 Ipamorelin
  1.2.5 TD-8954
  1.2.6 Others
1.3 United States Gastric Motility Disorder Drug Market by Application/End Users
  1.3.1 United States Gastric Motility Disorder Drug Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Home Use
1.4 United States Gastric Motility Disorder Drug Market by Region
  1.4.1 United States Gastric Motility Disorder Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Gastric Motility Disorder Drug Status and Prospect (2012-2022)
  1.4.3 Southwest Gastric Motility Disorder Drug Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Gastric Motility Disorder Drug Status and Prospect (2012-2022)
  1.4.5 New England Gastric Motility Disorder Drug Status and Prospect (2012-2022)
  1.4.6 The South Gastric Motility Disorder Drug Status and Prospect (2012-2022)
  1.4.7 The Midwest Gastric Motility Disorder Drug Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Gastric Motility Disorder Drug (2012-2022)
  1.5.1 United States Gastric Motility Disorder Drug Sales and Growth Rate (2012-2022)
  1.5.2 United States Gastric Motility Disorder Drug Revenue and Growth Rate (2012-2022)

2 UNITED STATES GASTRIC MOTILITY DISORDER DRUG MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Gastric Motility Disorder Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Gastric Motility Disorder Drug Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Gastric Motility Disorder Drug Average Price by Players/Suppliers (2012-2017)
2.4 United States Gastric Motility Disorder Drug Market Competitive Situation and Trends
  2.4.1 United States Gastric Motility Disorder Drug Market Concentration Rate
  2.4.2 United States Gastric Motility Disorder Drug Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Gastric Motility Disorder Drug Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES GASTRIC MOTILITY DISORDER DRUG SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Gastric Motility Disorder Drug Sales and Market Share by Region (2012-2017)
3.2 United States Gastric Motility Disorder Drug Revenue and Market Share by Region (2012-2017)
3.3 United States Gastric Motility Disorder Drug Price by Region (2012-2017)

4 UNITED STATES GASTRIC MOTILITY DISORDER DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Gastric Motility Disorder Drug Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Gastric Motility Disorder Drug Revenue and Market Share by Type (2012-2017)
4.3 United States Gastric Motility Disorder Drug Price by Type (2012-2017)
4.4 United States Gastric Motility Disorder Drug Sales Growth Rate by Type (2012-2017)

5 UNITED STATES GASTRIC MOTILITY DISORDER DRUG SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Gastric Motility Disorder Drug Sales and Market Share by Application (2012-2017)
5.2 United States Gastric Motility Disorder Drug Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES GASTRIC MOTILITY DISORDER DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Theravance, Inc.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Gastric Motility Disorder Drug Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Theravance, Inc. Gastric Motility Disorder Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Helsinn Healthcare S.A.
  6.2.2 Gastric Motility Disorder Drug Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Helsinn Healthcare S.A. Gastric Motility Disorder Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Concert Pharmaceuticals, Inc.
  6.3.2 Gastric Motility Disorder Drug Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Targacept, Inc.
  6.4.2 Gastric Motility Disorder Drug Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Targacept, Inc. Gastric Motility Disorder Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 ChironWells GmbH
  6.5.2 Gastric Motility Disorder Drug Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 ChironWells GmbH Gastric Motility Disorder Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview

7 GASTRIC MOTILITY DISORDER DRUG MANUFACTURING COST ANALYSIS

7.1 Gastric Motility Disorder Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Gastric Motility Disorder Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Gastric Motility Disorder Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Gastric Motility Disorder Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES GASTRIC MOTILITY DISORDER DRUG MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Gastric Motility Disorder Drug Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Gastric Motility Disorder Drug Sales Volume Forecast by Type (2017-2022)
11.3 United States Gastric Motility Disorder Drug Sales Volume Forecast by Application (2017-2022)
11.4 United States Gastric Motility Disorder Drug Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Gastric Motility Disorder Drug
Figure United States Gastric Motility Disorder Drug Market Size (K Pcs) by Type (2012-2022)
Figure United States Gastric Motility Disorder Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Velusetrag Product Picture
Figure Ipamorelin Product Picture
Figure TD-8954 Product Picture
Figure Others Product Picture
Figure United States Gastric Motility Disorder Drug Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Gastric Motility Disorder Drug by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Home Use Examples
Table Key Downstream Customer in Home Use
Figure United States Gastric Motility Disorder Drug Market Size (Million USD) by Region (2012-2022)
Figure The West Gastric Motility Disorder Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Gastric Motility Disorder Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Gastric Motility Disorder Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Gastric Motility Disorder Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Gastric Motility Disorder Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Gastric Motility Disorder Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Gastric Motility Disorder Drug Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Gastric Motility Disorder Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Gastric Motility Disorder Drug Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Gastric Motility Disorder Drug Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Gastric Motility Disorder Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Gastric Motility Disorder Drug Sales Share by Players/Suppliers
Figure 2017 United States Gastric Motility Disorder Drug Sales Share by Players/Suppliers
Figure United States Gastric Motility Disorder Drug Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Gastric Motility Disorder Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Gastric Motility Disorder Drug Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Gastric Motility Disorder Drug Revenue Share by Players/Suppliers
Figure 2017 United States Gastric Motility Disorder Drug Revenue Share by Players/Suppliers
Table United States Market Gastric Motility Disorder Drug Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Gastric Motility Disorder Drug Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Gastric Motility Disorder Drug Market Share of Top 3 Players/Suppliers
Figure United States Gastric Motility Disorder Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Gastric Motility Disorder Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Gastric Motility Disorder Drug Product Category
Table United States Gastric Motility Disorder Drug Sales (K Pcs) by Region (2012-2017)
Table United States Gastric Motility Disorder Drug Sales Share by Region (2012-2017)
Figure United States Gastric Motility Disorder Drug Sales Share by Region (2012-2017)
Figure United States Gastric Motility Disorder Drug Sales Market Share by Region in 2016
Table United States Gastric Motility Disorder Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Gastric Motility Disorder Drug Revenue Share by Region (2012-2017)
Figure United States Gastric Motility Disorder Drug Revenue Market Share by Region (2012-2017)
Figure United States Gastric Motility Disorder Drug Revenue Market Share by Region in 2016
Table United States Gastric Motility Disorder Drug Price (USD/Pcs) by Region (2012-2017)
Table United States Gastric Motility Disorder Drug Sales (K Pcs) by Type (2012-2017)
Table United States Gastric Motility Disorder Drug Sales Share by Type (2012-2017)
Figure United States Gastric Motility Disorder Drug Sales Share by Type (2012-2017)
Figure United States Gastric Motility Disorder Drug Sales Market Share by Type in 2016
Table United States Gastric Motility Disorder Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Gastric Motility Disorder Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Gastric Motility Disorder Drug by Type (2012-2017)
Figure Revenue Market Share of Gastric Motility Disorder Drug by Type in 2016
Table United States Gastric Motility Disorder Drug Price (USD/Pcs) by Types (2012-2017)
Figure United States Gastric Motility Disorder Drug Sales Growth Rate by Type (2012-2017)
Table United States Gastric Motility Disorder Drug Sales (K Pcs) by Application (2012-2017)
Table United States Gastric Motility Disorder Drug Sales Market Share by Application (2012-2017)
Figure United States Gastric Motility Disorder Drug Sales Market Share by Application (2012-2017)
Figure United States Gastric Motility Disorder Drug Sales Market Share by Application in 2016
Table United States Gastric Motility Disorder Drug Sales Growth Rate by Application (2012-2017)
Figure United States Gastric Motility Disorder Drug Sales Growth Rate by Application (2012-2017)
Table Theravance, Inc. Basic Information List
Table Theravance, Inc. Gastric Motility Disorder Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Theravance, Inc. Gastric Motility Disorder Drug Sales Growth Rate (2012-2017)
Figure Theravance, Inc. Gastric Motility Disorder Drug Sales Market Share in United States (2012-2017)
Figure Theravance, Inc. Gastric Motility Disorder Drug Revenue Market Share in United States (2012-2017)
Table Helsinn Healthcare S.A. Basic Information List
Table Helsinn Healthcare S.A. Gastric Motility Disorder Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Helsinn Healthcare S.A. Gastric Motility Disorder Drug Sales Growth Rate (2012-2017)
Figure Helsinn Healthcare S.A. Gastric Motility Disorder Drug Sales Market Share in United States (2012-2017)
Figure Helsinn Healthcare S.A. Gastric Motility Disorder Drug Revenue Market Share in United States (2012-2017)
Table Concert Pharmaceuticals, Inc. Basic Information List
Table Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Sales Growth Rate (2012-2017)
Figure Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Sales Market Share in United States (2012-2017)
Figure Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Revenue Market Share in United States (2012-2017)
Table Targacept, Inc. Basic Information List
Table Targacept, Inc. Gastric Motility Disorder Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Targacept, Inc. Gastric Motility Disorder Drug Sales Growth Rate (2012-2017)
Figure Targacept, Inc. Gastric Motility Disorder Drug Sales Market Share in United States (2012-2017)
Figure Targacept, Inc. Gastric Motility Disorder Drug Revenue Market Share in United States (2012-2017)
Table ChironWells GmbH Basic Information List
Table ChironWells GmbH Gastric Motility Disorder Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure ChironWells GmbH Gastric Motility Disorder Drug Sales Growth Rate (2012-2017)
Figure ChironWells GmbH Gastric Motility Disorder Drug Sales Market Share in United States (2012-2017)
Figure ChironWells GmbH Gastric Motility Disorder Drug Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gastric Motility Disorder Drug
Figure Manufacturing Process Analysis of Gastric Motility Disorder Drug
Figure Gastric Motility Disorder Drug Industrial Chain Analysis
Table Raw Materials Sources of Gastric Motility Disorder Drug Major Players/Suppliers in 2016
Table Major Buyers of Gastric Motility Disorder Drug
Table Distributors/Traders List
Figure United States Gastric Motility Disorder Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Gastric Motility Disorder Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Gastric Motility Disorder Drug Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Gastric Motility Disorder Drug Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Gastric Motility Disorder Drug Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Gastric Motility Disorder Drug Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Gastric Motility Disorder Drug Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Gastric Motility Disorder Drug Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Gastric Motility Disorder Drug Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Gastric Motility Disorder Drug Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Gastric Motility Disorder Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Gastric Motility Disorder Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Gastric Motility Disorder Drug Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories